Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

GlialCAM/MLC1 modulates LRRC8/VRAC currents in an indirect manner, Implications for megalencephalic leukoencephalopathy

  • Elorza-Vidal, Xabier
  • Sirisi Dolcet, Sonia|||0000-0002-5366-7832
  • Gaitan Peñas, Hector|||0000-0001-9797-903X
  • Pérez-Rius, Carla
  • Alonso-Gardón, Marta
  • Armand-Ugón, Mercedes|||0000-0002-4069-9915
  • Lanciottic, Angela
  • Stefani Brignonec, Maria
  • Prat, Esther|||0000-0001-5044-4468
  • Nunes Martínez, Virginia|||0000-0002-5747-9310
  • Ambrosini, Elena
  • Gasull, Xavier|||0000-0002-6154-8323
  • Estévez, Raúl|||0000-0003-1579-650X
Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare type of leukodystrophy caused by mutations in either MLC1 or GLIALCAM genes. Previous work indicated that chloride currents mediated by the volume-regulated anion channel (VRAC) and ClC-2 channels were affected in astrocytes deficient in either Mlc1 or Glialcam. ClC-2 forms a ternary complex with GlialCAM and MLC1. LRRC8 proteins have been identified recently as the molecular components of VRAC, but the relationship between MLC and LRRC8 proteins is unknown. Here, we first demonstrate that LRRC8 and MLC1 are functionally linked, as MLC1 cannot potentiate VRAC currents when LRRC8A, the main subunit of VRAC, is knocked down. We determine that LRRC8A and MLC1 do not co-localize or interact and, in Xenopus oocytes, MLC1 does not potentiate LRRC8-mediated VRAC currents, indicating that VRAC modulation in astrocytes by MLC1 may be indirect. Investigating the mechanism of modulation, we find that a lack of MLC1 does not influence either mRNA or total and plasma membrane protein levels of LRRC8A; and neither does it affect LRRC8A subcellular localization. In agreement with recent results that indicated that overexpression of MLC1 decreases the phosphorylation of extracellular signal-regulated kinases (ERK), we find that astrocytes lacking MLC1 show an increase in ERK phosphorylation. In astrocytes with reduced or increased levels of MLC1 we observe changes in the phosphorylation state of the VRAC subunit LRRC8C. Our results thus reinforce previous suggestions that indicated that GlialCAM/MLC1 might modify signal transduction pathways that influence the activity of different proteins, such as VRAC.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Exploring the Contribution of the Transporter AGT1/rBAT in Cystinuria Progression, Insights from Mouse Models and a Retrospective Cohort Study

  • Mayayo-Vallverdú, Clara|||0000-0003-0756-7790
  • Prat, Esther|||0000-0001-5044-4468
  • Vecino-Pérez, Marta
  • González Mera, Laura
  • Gràcia-Garcia, Silvia|||0000-0002-1838-5979
  • San Miguel, Luz
  • Lopera, Noelia
  • Arias, Angela
  • Artuch, R.|||0000-0002-3422-9685
  • López de Heredia, Miguel|||0000-0003-2826-9565
  • Torrecilla, Carlos
  • Rousaud-Barón, Ferran
  • Angerri Feu, Oriol|||0000-0003-3363-6585
  • Errasti-Murugarren, Ekaitz|||0000-0002-6054-7900
  • Nunes Martínez, Virginia|||0000-0002-5747-9310
More than 20 years have passed since the identification of SLC3A1 and SLC7A9 as causative genes for cystinuria. However, cystinuria patients exhibit significant variability in the age of lithiasis onset, recurrence, and response to treatment, suggesting the presence of modulatory factors influencing cystinuria severity. In 2016, a second renal cystine transporter, AGT1, encoded by the SLC7A13 gene, was discovered. Although it was discarded as a causative gene for cystinuria, its possible effect as a modulatory gene remains unexplored. Thus, we analyzed its function in mouse models of cystinuria, screened the SLC7A13 gene in 34 patients with different lithiasic phenotypes, and functionally characterized the identified variants. Mice results showed that AGT1/rBAT may have a protective role against cystine lithiasis. In addition, among the four missense variants detected in patients, two exhibited a 25% impairment in AGT1/rBAT transport. However, no correlation between SLC7A13 genotypes and lithiasis phenotypes was observed in patients, probably because these variants were found in heterozygous states. In conclusion, our results, consistent with a previous study, suggest that AGT1/rBAT does not have a relevant effect on cystinuria patients, although an impact in patients carrying homozygous pathogenic variants cannot be discarded.